Priority Health has chosen Arine, the medication intelligence company, as its partner in a value-based care endeavor that strives to optimize members' health outcomes.
Grand Rapids, Michigan — Wanting to identify the top medication management program for its members—encompassing medication therapy, reduced costs, and improved health outcomes—Priority Health in November chose Arine, the medication intelligence company, as its partner in this value-based care endeavor.
Arine’s artificial intelligence (AI) capabilities will enable the nonprofit health plan to continue providing optimal care to its members while also striving for top quality ratings for several CMS’ Part C and D Star measures. In particular, Arine’s AI has the ability to pinpoint safe and effective, individualized, medication regimens by examining clinical, socioeconomic, and behavioral data.
“Priority Health is committed to improving health outcomes for our members and reducing costs,” said Christina Barrington, vice president of pharmacy programs at Priority Health. “Through this partnership, our members will continue receiving the care they need, lower their prescription costs and receive personalized medication advice.”
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
QCCA, NCCA Merge to Form ONCare Among Independent Oncology Practices
February 29th 2024ONCare Alliance will be led by 2 of the leading women in community oncology, cochairs Barbara McAneny, MD, of the New Mexico Cancer Center, and Sibel Blau, MD, of Northwest Medical Specialties, PLLC, of Puyallup, Washington.
Read More